Literature DB >> 21424682

The adult asthmatic.

Amir A Zeki1, Nicholas J Kenyon, Ken Yoneda, Samuel Louie.   

Abstract

Asthma in the adult patient is a complex clinical syndrome. Multiple patient phenotypes and subphenotypes exist that contribute to disease heterogeneity. Whether adult asthma begins in utero, develops in childhood, or manifests for the first time in adulthood is not completely understood, nor are the mechanisms fully delineated. In this chapter, we update definitions that apply to this group, emphasize epidemiologic factors and pathogenic mechanisms, diagnosis, therapeutic options, and controversies regarding drug safety. Finally, we provide a brief discussion of biomarker technologies and novel therapies with the potential to impact adult-onset asthma outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21424682     DOI: 10.1007/s12016-011-8260-4

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  74 in total

1.  Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase.

Authors:  Kittipong Maneechotesuwan; Wuttichai Ekjiratrakul; Kanda Kasetsinsombat; Adisak Wongkajornsilp; Peter J Barnes
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

2.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

3.  Inflammatory subtypes in asthma: assessment and identification using induced sputum.

Authors:  Jodie L Simpson; Rodney Scott; Michael J Boyle; Peter G Gibson
Journal:  Respirology       Date:  2006-01       Impact factor: 6.424

4.  Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.

Authors:  M J Vaquerizo; P Casan; J Castillo; M Perpiña; J Sanchis; V Sobradillo; A Valencia; H Verea; J L Viejo; C Villasante; J Gonzalez-Esteban; C Picado
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

5.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

6.  Intrinsic asthma: not so different from allergic asthma but driven by superantigens?

Authors:  P J Barnes
Journal:  Clin Exp Allergy       Date:  2009-06-15       Impact factor: 5.018

7.  ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts.

Authors:  Augusto A Litonjua; Jessica Lasky-Su; Kady Schneiter; Kelan G Tantisira; Ross Lazarus; Barbara Klanderman; John J Lima; Charles G Irvin; Stephen P Peters; John P Hanrahan; Stephen B Liggett; Gregory A Hawkins; Deborah A Meyers; Eugene R Bleecker; Christoph Lange; Scott T Weiss
Journal:  Am J Respir Crit Care Med       Date:  2008-07-10       Impact factor: 21.405

8.  Randomized, placebo-controlled study of a selective PDE4 inhibitor in the treatment of asthma.

Authors:  Susan Lu; Nancy Liu; S Balachandra Dass; Theodore F Reiss; Barbara A Knorr
Journal:  Respir Med       Date:  2009-01-08       Impact factor: 3.415

9.  Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial.

Authors:  Mario Castro; Adalberto S Rubin; Michel Laviolette; Jussara Fiterman; Marina De Andrade Lima; Pallav L Shah; Elie Fiss; Ronald Olivenstein; Neil C Thomson; Robert M Niven; Ian D Pavord; Michael Simoff; David R Duhamel; Charlene McEvoy; Richard Barbers; Nicolaas H T Ten Hacken; Michael E Wechsler; Mark Holmes; Martin J Phillips; Serpil Erzurum; William Lunn; Elliot Israel; Nizar Jarjour; Monica Kraft; Narinder S Shargill; John Quiring; Scott M Berry; Gerard Cox
Journal:  Am J Respir Crit Care Med       Date:  2009-10-08       Impact factor: 21.405

10.  Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added].

Authors:  Antonius Schneider; Lisa Tilemann; Tjard Schermer; Lena Gindner; Gunter Laux; Joachim Szecsenyi; Franz Joachim Meyer
Journal:  Respir Res       Date:  2009-03-03
View more
  5 in total

1.  Editorial: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part II).

Authors:  Amir A Zeki; Behzad Yeganeh; Nicholas J Kenyon; Saeid Ghavami
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 2.  Evaluation and treatment of critical asthma syndrome in children.

Authors:  Alexander Wade; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

3.  Editorial (Thematic Issue: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part I)).

Authors:  Saeid Ghavami; Nicholas J Kenyon; Behzad Yeganeh; Amir A Zeki
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

4.  Urbanisation but not biomass fuel smoke exposure is associated with asthma prevalence in four resource-limited settings.

Authors:  Chelsea Gaviola; Catherine H Miele; Robert A Wise; Robert H Gilman; Devan Jaganath; J Jaime Miranda; Antonio Bernabe-Ortiz; Nadia N Hansel; William Checkley
Journal:  Thorax       Date:  2015-12-23       Impact factor: 9.139

Review 5.  Unmet needs in respiratory diseases : "You can't know where you are going until you know where you have been"--Anonymous.

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.